Cardioprotective effects of YM934, an ATP-sensitive potassium channel opener, on stunned myocardium in anesthetized dogs

General Pharmacology

Volumn 32, Issue 6, 1999, Pages 695-703

  Taguchi, Taku ^a   Uchida, Wataru ^a   Takenaka, Toichi ^a   Takeo, Satoshi ^b  

^a Neuroscience Research   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Adenosine triphosphate (ATP) sensitive potassium channel opener; ATP sensitive potassium channel blocker; Cardioprotection; Ischemia; Regional myocardial blood flow; Stunned myocardium

Indexed keywords

2 (3,4 DIHYDRO 2,2 DIMETHYL 6 NITRO 2H 1,4 BENZOXAZIN 4 YL)PYRIDINE 1 OXIDE; GLIBENCLAMIDE; HYDRALAZINE; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEMODYNAMICS; INOTROPISM; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STUNNED HEART MUSCLE;

ADENOSINE TRIPHOSPHATE; ANESTHESIA; ANIMALS; CORONARY CIRCULATION; CYCLIC N-OXIDES; DOGS; FEMALE; GLYBURIDE; HEMODYNAMIC PROCESSES; HYDRAZINES; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIAL STUNNING; OXAZINES; POTASSIUM CHANNELS; REGIONAL BLOOD FLOW; VASODILATOR AGENTS;

EID: 0033057750     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00237-7     Document Type: Article

References (28)

1. Abel F.L. Maximal negative dP/dt as an indicator of end of systole. Am J Physiol. 240:1981;H676-H679.
2. Auchampach J.A., Maruyama M., Cavero I., Gross G.J. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
3. Bolli R., Zhu W.X., Thornby J.I., O'Neill P.G., Roberts R. Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 254:1988;H102-H114.
4. Bolli R. Common methodological problems and artifacts associated with studies of myocardial stunning in vivo. Basic Res Cardiol. 90:1995;257-262.
5. Braunwald E., Kloner R.A. The stunned myocardium. Prolonged, postischemic ventricular dysfunction Circulation. 66:1982;1146-1149.
6. D'Alonzo A.J., Darbenzio R.B., Parham C.S., Grover G.J. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res. 26:1992;1046-1053.
7. Grover G.J., Sleph P.G., Dzwonczyk S. Nicorandil improves postischemic contractile function independently of direct myocardial effects. J Cardiovasc Pharmacol. 15:1990;698-705.
8. Grover G.J., Newburger J., Sleph P.G., Dzwonczyk S., Taylor S.C., Ahmed S.Z., Atwal K.S. Cardioprotective effects of the potassium channel opener cromakalim. Stereoselectivity and effects on myocardial adenine nucleotides J Pharmacol Exp Ther. 257:1991;156-162.
9. Hakkinen J.P., Miller M.W., Smith A.H., Knight D.R. Measurement of organ blood flow with colored microspheres in the rat. Cardiovasc Res. 29:1995;74-79.
10. Heusch G. The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium. Basic Res Cardiol. 86:1991;197-218.
11. Heyndrickx G.R., Baig H., Nellers P., Levsen L., Fishbein M.C., Vatner S.F. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol. 234:1978;H653-H659.
12. Kusuoka H., Kitakaze M., Koretsune Y., Inoue M., Marban E. Pathophysiology and pathogenesis of contractile failure in stunned myocardium. Jpn Circ J. 55:1991;878-884.
13. 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA. 842:1987;6005-6009.
14. Nachlas M.U., Shnitka T.K. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol. 42:1963;379-405.
15. Pagani M., Vatner S.F., Baig H., Braunwald E. Initial adjustments to brief periods of ischemia and reperfusion in the conscious dog. Circ Res. 43:1978;83-92.
16. Patel B., Kloner R.A., Przyklenk K., Braunwald E. Postischemic myocardial stunning. a clinically relevant phenomenon Ann. Intern. Med. 108:1988;627-629.
17. Puli P.S. Contractile and biochemical effects of coronary reperfusion after extended periods of coronary occlusion. Am J Cardiol. 36:1975;244-251.
18. Reimer K.A., Hill M.L., Jennings R.B. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol. 13:1981;229-239.
19. Renkin J., Wijns W., Ladha Z., Col J. Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, permanent T wave inversion, and left anterior descending coronary artery stenosis. Circulation. 82:1990;913-921.
20. Rohmann S., Weygandt H., Schelling P., Soei L.K., Becker K.-H., Verdouw P.D., Lues Y., Hausler G. Effect of bimakalim (EMD52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine. Cardiovasc Res. 28:1994;858-863.
21. Stahl L.D., Aversano T.R., Becker L.C. Selective enhancement of function of stunned myocardium by increased flow. Circulation. 74:1986;843-851.
22. Swain J.L., Sabina R.L., McHale P.A., Greenfield J.C., Holmes E.W. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog. Am J Physiol. 242:1982;H818-H826.
23. Touchstone D.A., Beller G.A., Nygaard T.W., Tedesco F.C., Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans. A topographic assessment using two-dimensional echocardiography J Am Collardio l. 13:1989;1506-1513.
24. Uchida W., Masuda N., Taguchi T., Shibasaki K., Shirai Y., Asano M., Matsumoto Y., Tsuzuki R., Fujikura T., Takenaka T. Pharmacologic profiles of YM934, a novel potassium channel opener. J Cardiovasc Pharmacol. 23:1994;180-187.
25. Weiner J.M., Apstein C.S., Arthur J.H., Pirzada F.A., Hood W.B. Persistence of myocardial injury following brief periods of coronary occlusion. Cardiovasc Res. 10:1976;678-686.
26. Wijns W., Serruys P.W., Slager C.J., Grimm J., Krayenbuehl H.P., Hugenholtz P.G., Hess O.M. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J Am Coll Cardiol. 7:1986;455-463.
27. Wood J.M., Hanley H.G., Entman M.L., Hartley C.J., Swain J.A., Busch U., Chang C.H., Lewis R.M., Morgan W.J., Schwartz A. Biochemical and morphological correlates of acute experimental myocardial ischemia in the dog. IV. Energy mechanisms during very early ischemia. Circ Res. 44:1979;52-61.
28. + channels in cardiac myocytes. J Pharmacol Exp Ther. 267:1993;1544-1549.